Home » Healthcare » Pharmaceuticals » Ultrasound Contrast Agents Market

Ultrasound Contrast Agents Market: Growth, Future Prospects & Competitive Analysis, 2018-2026

Price: $4999

Published: | Report ID: 10892 | Report Format : PDF


Ultrasound contrast agents are used to perform or conduct contrast-enhanced ultrasound (CEUS) procedures. Microbubble contrast agents are small, spherical bubbles with three phases, such as the innermost gas phase, the shell material enclosing the gas phase, and the outermost gas or liquid phase. These microbubbles have the unique ability to respond to ultrasound, hence their use for ultrasound imaging and research. These bubbles improve the visualization of blood flow pertaining to the surrounding tissue. Microbubbles are micron-sized (smaller than one millimeter in diameter) particles consisting of a gas core surrounded by a lipid shell. On the other side, perfluorocarbons (PFCs) are fluorinated compounds used as contrast agents for ultrasonography and magnetic resonance imaging (MRI). The contrast agents, which contain liquid perfluorocarbons, are used in contrast-enhanced ultrasound procedures.

Design Element 2

Access crucial information at unmatched prices!

Request your free sample report today & start making informed decisions powered by Credence Research!

Download Free Sample

CTA Design Element 3

Technological advances in ultrasound technologies and the advantages of ultrasound over alternative technologies are majorly driving the demand for ultrasound contrast agents over the forecast period. Furthermore, a growing geriatric population, coupled with the rising prevalence of chronic diseases and rising demand for diagnostics and image-guided procedures, is expected to support market growth during the forecast period. Moreover, the presence of favorable government initiatives, promising reimbursement policies for contrast-enhanced procedures, and rising research activities related to enhancing imaging and diagnosis outcomes are likely to assist in the market’s growth.

Based on the therapeutic area, the cardiovascular diseases segment is expected to dominate the market from 2018 to 2026 owing to the extensive use of ultrasound contrast agents in echocardiography procedures and the increasing burden of stroke and heart attack. The presence of major market participants (suppliers and distributors), a sophisticated healthcare system, and comparatively higher adoption of advanced technologies are expected to put North America in the dominant position over the forecast period. Asia Pacific is anticipated to register a comparatively higher CAGR during the forecast period owing to its growing aging population base, rising prevalence of chronic diseases, and increasing healthcare spending.

Shape Your Report to Specific Countries or Regions & Enjoy 30% Off!

The global ultrasound contrast agents market is classified as follows:

  • Global Ultrasound Contrast Agents Market by Product (US$ Mn), 2016-2026
    • Microbubbles and Contrast Agents
    • Liquid Perfluorocarbon Nanoemulsion Contrast Agents
  • Global Ultrasound Contrast Agents Market by Therapeutic Area (US$ Mn), 2016-2026
    • Cardiovascular Diseases
    • Kidney Diseases
    • Cancer
    • Others
  • Global Ultrasound Contrast Agents Market by Application (US$ Mn), 2016-2026
    • Hospitals
    • Diagnostic Imaging Centers
    • Academic and Research Centers
    • Others
  • Global Ultrasound Contrast Agents Market by Geography (US$ Mn), 2016-2026

North America

  • U.S.
  • Canada


  • U.K.
  • Germany

Rest of Europe

  • Asia-Pacific (APAC)
  • Japan
  • China
  • Rest of APAC

Latin America (LATAM)

  • Brazil
  • Mexico
  • Rest of LATAM

Middle East and Africa (MEA)

  • GCC
  • the remainder of MEA

Key players identified in the global ultrasound contrast agents market include:

  • GE Healthcare
  • Lantheus Medical Imaging, Inc.
  • Bracco Imaging S.p.A.
  • Daiichi Sankyo Company, Limited
  • nanoPET Pharma GmbH
  • FUJIFILM Holdings Corporation

This report offers the following:

  • Comprehensive overview of the global ultrasound contrast agents market, including the current and future market dynamics.
  • Elucidation of each market segment based on recent product approvals, launches, and current and anticipated market dynamics
  • Company profiles and competitive landscape of the leaders operating in the ultrasound contrast agents market based on key products, operating business areas, financial analysis, and recent strategic developments

Frequently Asked Questions:

What is the size of Ultrasound Contrast Agents Market?

The market for Ultrasound Contrast Agents is expected to reach US$ XX Bn in 2026.

What is the Ultrasound Contrast Agents Market CAGR?

The Ultrasound Contrast Agents market is expected to see significant CAGR growth over the coming years,at XX%.

What is the Forecast period considered for Ultrasound Contrast Agents Market?

The report is forecasted from 2018-2026.

What is the base year considered for Ultrasound Contrast Agents Market?

The base year of this report is 2017.

Who are the major players in this market?

GE Healthcare, Lantheus Medical Imaging, Inc., Bracco Imaging S.p.A., Daiichi Sankyo Company, Limited, nanoPET Pharma GmbH are some of the major players in the global market.

US Addiction Treatment Market

Report ID: 43690

Gaucher Disease Therapeutics Market

Report ID: 12699

Obesity Diabetes Drugs Market

Report ID: 43145

Trigeminal Neuralgia Treatment Market

Report ID: 11788

Pompe Disease Therapeutics Market

Report ID: 5989

Pre-Menstrual Syndrome Treatment Market

Report ID: 11248

Vial Adaptors for Reconstitution Drug Market

Report ID: 15561

Psychedelic Medicine Market

Report ID: 41606

Hospital Infection Prevention And Control Market

Report ID: 7217

Nanoparticle Formulation Market

Report ID: 41106

Animal Drug Compounding Market

Report ID: 40870

Antibiotics Market

Report ID: 40728

Purchase Options

Delivery Format: Excel.
Designed for the individual purchaser.
Users located at a single corporate site or regional office.
Allowed for unlimited sharing globally within one company.
Smallform of Sample request

Have a question?

User Profile

Don’t settle for less – trust Mitul to help you find the best solution.

Report delivery within 24 to 48 hours

– Other Info –

What people say?-

User Review

I am very impressed with the information in this report. The author clearly did their research when they came up with this product and it has already given me a lot of ideas.

Jana Schmidt
CEDAR CX Technologies

– Connect with us –


+91 6232 49 3207


24/7 Research Support


– Research Methodology –

Going beyond the basics: advanced techniques in research methodology

– Trusted By –

Pepshi, LG, Nestle
Motorola, Honeywell, Johnson and johnson
LG Chem, SIEMENS, Pfizer
Unilever, Samsonite, QIAGEN